Login / Signup

3D image-guided treatment planning for Ruthenium-106 brachytherapy of choroidal melanomas.

Charlotte A EspensenJens Folke KiilgaardKristian KlempAnita B GothelfAne L AppeltLotte S Fog
Published in: Acta ophthalmologica (2020)
3D treatment planning theoretically allows for improved tumour dose delivery for Ru-106 brachytherapy of choroidal melanomas, resulting in a significant increase in expected tumour control compared to traditional approaches using 2D calculations. The deliverability of optimized plans, and potential increased risk of late complications, will have to be confirmed in future clinical studies.
Keyphrases